LIC Increases Stake in Biocon to 5.02%

By By Rediff Money Desk, New Delhi
Sep 17, 2024 21:23
Life Insurance Corporation of India (LIC) has raised its stake in Biocon Ltd to 5.02%, increasing its shareholding from 4.98% to 5.02%.
New Delhi, Sep 17 (PTI) Life Insurance Corporation (LIC) on Tuesday said it has increased its stake in pharma firm Biocon to 5.02 per cent.

Earlier, LIC had 4.98 per cent stake in the pharma company.

"Life Insurance Corporation of India has increased its shareholding in equity shares of Biocon Ltd from 5,98,14,429 to 6,03,14,429 i.e, 4.982 per cent to 5.023 per cent of the paid-up capital of the said company," the insurer said in a regulatory filing.
Source: PTI
Read More On:
licbioconshareholdingstake increasepharma company
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

SBI MD: Concerns Over Account Aggregator Consent

SBI MD Ashwini Kumar Tewari raises concerns about Account Aggregator's single consent...

Silver Hits Record High on Fed Rate Cut Hopes

Silver futures soar to Rs 1.91 lakh/kg on Fed rate cut expectations. Gold rises. Market...

SpiceJet Adds 100 Daily Flights for Winter Demand

SpiceJet plans to add up to 100 daily flights this winter to meet growing demand and...

2 Lakh Startups Recognised by Govt: Startup India

Government recognizes over 2 lakh startups under Startup India. Incentives, job...

Waaree Energies: 1 GW Solar Module Output Record

Waaree Energies achieves record 1 GW monthly solar module output in November 2025, a...

India FTA Talks with Oman, New Zealand Nearing End

Piyush Goyal announces FTA negotiations with Oman, New Zealand in final stages. Trade...

Telangana to Launch Rs 1,000 Cr Startup Fund

Telangana CM announces Rs 1,000 crore startup fund to boost Hyderabad as a unicorn hub....

ADB Raises India GDP Growth Forecast to 7.2%...

ADB sharply revises India''s GDP growth forecast upward to 7.2% for FY26, driven by...

India, EU FTA Talks Progress: Goyal Comments

Piyush Goyal says India and EU are committed to early conclusion of FTA negotiations. A...

Zydus Launches Denosumab Biosimilar Zyrifa

Zydus Lifesciences launches Zyrifa, a Denosumab biosimilar for osteoporosis and...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com